1. Chapter 2.6.9: Abnormal toxicity;European Pharmacopoeia (8.0),2013
2. U.S. Food and Drug Administration's Code of Federal Regulations (CFR), title 21, part 610: General biological products standards;US Food and Drug Administration. rev,2013
3. Expert Committee on Biological Standardization;World Health Organization,1990
4. The state control of immunosera;Otto,1906
5. Technology of vaccines and immunosera;Marxer,1915